COMPOUND WITH CONFIDENCE: PCCA Membership, $795/month.

Pharmacy compounding's source for clinical information, regulatory updates, and opportunities

THE PCCA BLOG

rss

Stay current on PCCA news and events, market trends, and all things compounding!

USP-NF_and_US_Pharmacist_Featuring_Proprietary_PCCA_Bases.jpg

USP–NF and U.S. Pharmacist Featuring Proprietary PCCA Bases

Maria Carvalho discusses the latest versions of the USP (43rd edition) and NF (38th edition), as well as the corresponding USP Compounding Compendium, recognizing the importance of several proprietary PCCA bases

Read More
Upcoming_Changes_to_PCCA_Formulas_per_the_New_USP_795_797_and_800_Part_Two.png

Upcoming Changes to PCCA Formulas per the New USP <795>, <797> and <800> (Part Two)

PCCA's Director of Formulation Development Melissa Merrell Rhoads, PharmD, provides part two in a set of posts detailing the upcoming changes to our formulas based upon the new USP guidelines. This particular section focuses on USP <797>.

Read More
Upcoming_Changes_to_PCCA_Formulas_per_the_New_USP_795_797_and_800_Part_One.png

Upcoming Changes to PCCA Formulas per the New USP <795>, <797> and <800> (Part One)

PCCA's Director of Formulation Development Melissa Merrell Rhoads, PharmD, provides part one in a set of posts detailing the upcoming changes to our formulas based upon the new USP guidelines.

Read More
PCCA Blog - 2018 - USP 795 and BUDs - Main Image 03.png

What the Proposed USP <795> Revisions Mean for BUDs

On March 30, 2018, the Compounding Expert Committee of the United States Pharmacopeial Convention published proposed revisions to USP chapter <795> Pharmaceutical Compounding – Nonsterile Preparations. The revised chapter was open to public comments until July 31, 2018, and is expected to become official on December 1, 2019. Major revisions to the chapter include, but are not limited to, the following:

Read More